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Abstract
Background: The type III secretion system (TTSS) is an important virulence determinant of
Gram-negative bacterial pathogens. It enables the injection of effector proteins into the cytosol
of eukaryotic cells. These effectors ultimately manipulate the cellular functions of the infected
organism. Salmonella enterica serovar Typhimurium encodes two virulence associated TTSSs
encoded by the Salmonella Pathogenicity Islands (SPI) 1 and 2 that are required for the intestinal
and systemic phases of the infection, respectively. However, recent studies suggest that the roles
of these TTSSs are not restricted to these compartments. The regulation of TTSSs in Salmonella
is very complex with several regulators operating to activate or to repress expression depending
on the environmental conditions.
Results: We performed a systematic analysis of the regulation of type III effectors during growth
in vitro. We have tested the ability of seven regulatory genes to regulate ten effector genes. Each
regulator was expressed in the absence of the other six to avoid cascade effects. Our results
confirm and extend the previously reported regulation of TTSS1 and TTSS2 effectors by InvF-
SicA and SsrB respectively.
Conclusion:  The set of strains constructed for this study can be used to quickly and
systematically study the regulation of newly identified effector genes of Salmonella enterica. The
approach we have used can also be applied to study complex regulatory cascades in other
bacterial species.
Background
The type III secretion system (TTSS) is a complex molecu-
lar machine found in numerous Gram-negative bacterial
pathogens of animals and plants [1]. This secretion sys-
tem encodes a syringe-like organelle that injects effector
proteins directly into the cytosol of eukaryotic cells. The
effectors ultimately affect host cell physiology.
S. enterica serovar Typhimurium (hereafter referred to
simply as Typhimurium) possesses two virulence associ-
ated TTSSs encoded by the Salmonella  Pathogenicity
Islands (SPI) 1 and 2 [2]. TTSS1 (encoded by SPI1) deliv-
ers effectors that mediate the invasion of epithelial cells
and the intestinal events of Typhimurium infection [3-5].
TTSS2 is required during the systemic phase of Typhimu-
rium infection [6]. It secretes effectors that allow the sur-
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vival and multiplication of the pathogen within
macrophages [7]. The regulation of the Typhimurium
TTSSs is complex with several regulatory proteins involved
(Figure 1). SPI1 encodes five regulators, four of which are
known to be involved in regulatory cascades that lead to
the expression of genes inside and outside of SPI1 [8]. The
central regulator of SPI1 gene expression is HilA, a mem-
ber of the OmpR/ToxR family [5,8]. HilA directly activates
the expression of two SPI1 operons that encode TTSS1
apparatus components [5,9]. One of these operons begins
with the invF gene, which encodes a transcriptional activa-
tor of the AraC family. InvF activates the expression of
TTSS1 effectors encoded both inside and outside of SPI1
[10,11]. The activity of InvF requires the SicA co-regulator
which is also encoded within SPI1 [12,13]. The third and
fourth regulators are HilC and HilD, both of which
belong to the AraC family. Both can directly activate the
expression of hilA  [14,15]. They can also activate the
expression of the invF  operon independently of HilA
[16,17]. The fifth regulator encoded within SPI1, SprB,
contains a LuxR/UhpA helix-turn-helix motif, however no
target genes for SprB have been identified [18].
SPI1 gene expression is also regulated by factors encoded
outside of SPI1 (Figure 1A). The SirA/BarA two-compo-
nent system is an ancient regulatory system with
orthologs found throughout the γ-proteobacteria that is
involved in virulence gene expression, exoenzyme and
antibiotic production, motility, and biofilm formation
[19,20]. In Typhimurium, SirA has been shown to bind
and activate the promoters of hilC and hilA [21], although
an alternate model has also been proposed in which SirA
acts through hilD rather than through hilA and hilC [22].
Additional regulators of SPI1 gene expression encoded
outside of SPI1 include the two-component regulatory
systems PhoPQ [23], PhoBR [24], and OmpR/EnvZ [24],
and the AraC-like transcriptional activator RtsA [25]. How
these regulatory inputs are integrated is not yet known.
The central regulator of SPI2, and some TTSS2 effector
genes located outside of SPI2, is the SsrAB two-compo-
nent system [26]. SsrB has been shown to bind and acti-
vate the promoter of the srfH/sseI  gene that encodes a
TTSS2 effector [27]. Similarly, SsrB is thought to directly
activate the expression of SPI2 operons as well as other
Regulatory cascades activating the expression of SPI1 (A) and SPI2 (B) related type III effectors Figure 1
Regulatory cascades activating the expression of SPI1 (A) and SPI2 (B) related type III effectors. The regulators analyzed in this 
study are represented in circled boxes.
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effector genes located outside of SPI2 [28,29]. The expres-
sion of ssrA and ssrB is activated by factors encoded out-
side of SPI2 (Figure 1B). These include the two-
component systems OmpR/EnvZ [30], PhoPQ [31], and
the slyA gene [32]. Recently the ydgT gene was identified as
a negative regulator of SPI2 gene expression [33].
The effectors secreted by TTSS1 are required for the inva-
sion of intestinal epithelial cells [4,34]. In contrast, the
SPI2 genes are induced after Typhimurium has invaded or
is phagocytized by eukaryotic cells [29,31,35-37]. These
observations led to the hypothesis that TTSS1 is needed to
invade intestinal cells, but is not required during the sub-
sequent phases of Typhimurium pathogenesis, while
TTSS2 is expressed only when the bacteria reside within
eukaryotic cells. Several recent reports suggest a more
complicated role of the Typhimurium TTSSs. For example,
SPI1 mutants have a replication defect and are unable to
synthesize a normal SCV inside epithelial cells suggesting
that SPI1 genes are involved in these functions [38]. Con-
versely, SPI2 genes have been shown to be involved in the
induction of the inflammatory response caused by S.
enterica  serovar Dublin in a bovine ligated-ileal-loop
model [39] and to be essential for the full virulence of
Typhimurium in murine infectious enterocolitis [40,41].
These results suggest that each TTSS might be expressed in
different compartments within the host, and that at least
some effectors might be involved in more than one phase
of the infection.
Given the complexity of these regulatory hierarchies, we
took a systematic in vitro approach to categorizing the reg-
ulatory inputs of effector genes in Typhimurium. Besides
examining the effects of individual regulatory mutations
on individual effectors, we wanted to test each regulatory
gene in the absence of other regulators. For example, the
regulatory hierarchy for SPI1 is complex in that SirA acti-
vates hilA and hilC, HilC also activates hilA, and HilA and
HilC in turn activate invF. InvF combined with SicA then
activates effector genes. Since mutations anywhere in the
cascade can cause loss of effector gene expression, we
chose to test individual members of the cascade for activa-
tion of each effector in the absence of all other members
of the cascade. This type of approach could reveal if, for
instance, sirA, hilA, or hilC can regulate any effectors inde-
pendently of invF. This approach might also reveal novel
regulatory patterns for individual effectors, for example,
effector genes regulated by both SPI1 and SPI2 regulators.
Therefore, in this report we have examined the effects of
seven regulatory genes on ten effector genes. The expres-
sion of each effector gene was examined in a set of strains
lacking all but one of the seven regulators. Our results
confirm and extend the known regulation of TTSS1 and
TTSS2 effectors by invF-sicA and ssrB respectively.
Results and discussion
Construction of Typhimurium multi-regulator mutant 
strains harboring lacZY fusions to type III effector genes
We constructed a Typhimurium strain that lacks seven reg-
ulators, six of which are known to affect the expression of
the type III secretion systems of this bacterium. The
TTSS1-encoding region of SPI1, which harbors five regula-
tory genes (hilC, hilD, hilA, invF and sprB) and a co-regu-
lator (sicA), was deleted in a strain that harbors a
mutation of the sirA gene (see Materials and Methods).
Transduction of an ssrB mutation into this strain resulted
in YD038 which lacks seven regulatory genes (hereafter
known as the multi-mutant). Chromosomal lacZY tran-
scriptional fusions to ten effector genes were then con-
structed in YD038. These included fusions to genes that
encode effectors secreted by TTSS1 (sopA, sopB and sopE2),
TTSS2 (sspH2, sifA, sifB, sseI, and sseG) or both (slrP and
sspH1). These ten fusions were also transduced into the
wild type strain, 14028, using phage P22HTint.
Effects of individual regulators on the expression of the 
type III secreted effectors
Low copy number plasmids individually encoding seven
regulators of SPI1 or SPI2 (or the vector control) were
transformed into each of the ten strains that carry a lacZY
fusion in the multi-mutant background. Each plasmid
was constructed in such a way as to have the regulatory
gene expressed from the vector's lac promoter. Expression
and regulatory activity of the resulting constructs was con-
firmed using complementation tests with known target
genes (Figure 2). The only exception was sprB for which
the target genes are not known. The resulting 80 strains
(and the ten additional strains harboring the same fusions
in the wild-type background) were then grown in tripli-
cate to log phase under either SPI1-inducing conditions
(LB broth standing at 37°C overnight [42]) or SPI2-induc-
ing conditions (MgM broth shaking at 37°C until OD595
of 0.2 to 0.8). The β-galactosidase activity of the strains
was then determined. The results of SPI1-inducing condi-
tions are shown in Table 1 and the results of SPI2-induc-
ing conditions are shown in Table 2. For all of the
discussion below, any effect less than 3-fold is considered
to be no effect.
• TTSS1 effectors
Regardless of growth conditions, the fusions to sopA, sopB,
and sopE2 produced more β-galactosidase in the wild type
than in the multi-mutant vector control suggesting that a
regulatory factor is missing in the multi-mutant (Tables 1
and 2). For sopA the invF-sicA plasmid was the only plas-
mid that restored expression. Expression of the sopB
fusion was also restored by the invF-sicA plasmid. These
results confirm previous findings in which invF-sicA acti-
vates sopA and sopB [10,25]. Interestingly, the ssrB plasmid
also partially restored sopB expression, but only in SPI1-BMC Microbiology 2007, 7:3 http://www.biomedcentral.com/1471-2180/7/3
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inducing conditions. This is a novel result but the effect of
ssrB is quite small compared to the effect of invF so it is not
clear if it is physiologically relevant.
The expression of the sopE2 fusion was decreased in the
multi-mutant background and the invF-sicA  plasmid
restored expression (Tables 1 and 2). The activation of
sopE2 by invF-sicA has not been previously reported. How-
ever, a homolog of sopE2, the sopE gene, has been shown
to be regulated by invF-sicA [12]. The sopE2 gene is present
in all Salmonella serovars examined to date, while the pres-
ence of sopE  is sporadic [43]. The sopE  gene was not
included in this study because it is not present in our wild-
type 14028 strain. Our results suggest that in addition to
their similar function, sopE and sopE2 are both regulated
by invF-sicA.
Additionally, all of the above results indicate that the reg-
ulators above invF in the SPI1 regulatory cascade (sirA,
hilA, hilC, hilD) cannot regulate sopA, sopB, or sopE2 in the
absence of invF.
• slrP and sspH1
SspHl and SlrP are known to be secreted by both TTSS1
and TTSS2 [28,44]. The sspH1 fusion was not decreased in
the multi-mutant background compared to the wild-type
in either SPI1 or SPI2-inducing conditions, suggesting
that none of the seven regulators control sspH1. However,
the invF-sicA plasmid activated the sspH1 fusion by 4-fold
compared to the vector control in SPI1-inducing condi-
tions (Table 1). Previously Miao and Miller found that the
expression of sspH1 is constitutive [44], so it is not clear if
the 4-fold effect of a plasmid-encoded regulator is physio-
logically significant.
Expression of the slrP fusion did not decrease in the multi-
mutant background in either growth condition, but it was
activated 12-fold and 4-fold in the presence of the sprB
and invF-sicA plasmids, respectively. This effect was only
seen in SPI1-inducing conditions. Both of these results are
interesting since no target has been identified for sprB, and
invF-sicA  was not known to regulate slrP. It has been
reported that while chromosomal hilC and hilD have no
effect on slrP, plasmid-encoded hilC and hilD do moder-
ately activate slrP expression [25]. In this study, the slrP
fusion was induced neither by hilC nor by hilD in the
multi-mutant background suggesting that the previously
observed regulation of slrP by hilC and hilD is through
invF.
To test the activation of the slrP fusion by chromosomal
sprB  and  invF-sicA, mutations in these regulators were
Functional verification of regulator-encoding plasmids Figure 2
Functional verification of regulator-encoding plasmids. Each regulatory gene, cloned into the pWSK29 vector, was introduced 
into a strain containing a mutation of the corresponding regulator and a lacZY reporter to a gene known to be activated by the 
regulator (The hilC-encoding plasmid was introduced into the wild type strain and compared to the control vector). β-galactos-
idase assays were performed on log-phase cultures (using ONPG) and the results represent a mean of at least three independ-
ent assays. (A) An invF::Tn5-lacZY reporter was used to verify the plasmids encoding hilA, hilC, hilD and sirA. (B) A sopB-lacZY 
fusion was used for the plasmid encoding invF and sicA; and (C), a srfH::MudJ reporter for the plasmid encoding ssrB.
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Table 1: Regulatory dependence of type III secreted effectors under SPI-1 inducing conditions.
AB C D E FG HI
wild type MM+ pWSK29 MM sprB+ MM hilC+ MM hilD+ MM hilA + MM invF+ sicA + MM ssrB+ MM sirA +
1 sopA-lacZ 7685 ± 1026 23 ± 1 1 ± 2 0 ± 2 1 ± 2 9 ± 3 4982 ± 625 9 ± 3 1 ± 1
2 sopB-lacZ 10981 ± 922 148 ± 11 85 ± 2 75 ± 8 82 ± 4 199 ± 15 56160 ± 4842 3095 ± 1711 113 ± 8
3 sopE2-lacZ 14251 ± 4224 1872 ± 252 2425 ± 748 2477 ± 281 1093 ± 391 3735 ± 65 31415 ± 1109 3963 ± 90 2574 ± 69
4 slrP-lacZ 385 ± 44 305 ± 5 3511 ± 349 295 ± 164 448 ± 78 403 ± 87 1282 ± 138 308 ± 39 621 ± 23
5 sspHl-lacZ 796 ± 196 689 ± 26 697 ± 165 668 ± 98 949 ± 103 960 ± 146 2906 ± 585 827 ± 165 666 ± 67
6 sspH2-lacZ 360 ± 34 326 ± 38 412 ± 128 225 ± 16 389 ± 71 453 ± 90 359 ± 24 15685 ± 1481 296 ± 11
7 sifA-lacZ 21664 ± 538 10321 ± 719 9970 ± 528 9232 ± 665 9611 ± 887 10176 ± 817 10329 ± 1153 14085 ± 429 16738 ± 1612
8 sifB-lacZ 65 ± 2 939 ± 81 1393 ± 849 19 ± 5 1537 ± 470 809 ± 150 30 ± 6 14334 ± 2904 25 ± 6
9 sseI-lacZ 70 ± 4 60 ± 10 69 ± 22 32 ± 2 43 ± 5 61 ± 15 47 ± 10 5154 ± 1291 60 ± 15
10 sseG-lacZ 1931 ± 36 2046 ± 440 1153 ± 257 3001 ± 297 2083 ± 442 2872 ± 314 2444 ± 554 25454 ± 314 919 ± 73
The lac fusion being measured is listed in the left column. The strain background is listed along the top. Each strain harbors a lac fusion to an effector and a plasmid encoding a regulator or the vector control. 
The values in bold are those showing greater than 3-fold differences compared to the MM + pWSK29 strain that are discussed in the text. Each value represents the mean of at least three experiments ± 
standard deviation. MM, multi-regulator mutant [∆(avrA-invH)1 ssrB::cat sirA4::hyg].B
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Table 2: Regulatory dependence of type III secreted effectors under SPI-2 inducing conditions.
AB CDEF G H I
wild type MM + pWSK29 MM sprB+ MM hilC+ MM hilD+ MM hilA + MM invF+sicA + MM ssrB+ MM sirA +
1 sopA-lacZ 1221 ± 35 35 ± 13 24 ± 7 19 ± 7 26 ± 7 48 ± 17 6129 ± 1152 75 ± 36 33 ± 6
2 sopB-lacZ 3573 ± 34 99 ± 5 61 ± 7 61 ± 15 78 ± 10 44 ± 3 219791 ± 11811 33 ± 15 46 ± 5
3 sopE2-lacZ 3530 ± 270 5406 ± 547 4807 ± 538 7285 ± 1182 2347 ± 35 7141 ± 852 49681 ± 5581 7141 ± 2059 5222 ± 350
4 slrP-lacZ 1650 ± 24 1222 ± 92 3091 ± 43 1108 ± 132 1211 ± 163 1688 ± 523 1858 ± 238 1901 ± 311 2146 ± 34
5 sspH1-lacZ 3744 ± 140 1908 ± 254 1772 ± 471 1686 ± 161 1420 ± 116 1950 ± 128 3558 ± 232 3947 ± 978 1951 ± 154
6 sspH2-lacZ 6482 ± 1779 764 ± 123 1006 ± 48 655 ± 80 625 ± 84 981 ± 35 850 ± 102 62305 ± 14432 890 ± 111
7 sifA-lacZ 9995 ± 1326 13634 ± 1478 11691 ± 1186 10521 ± 1782 12603 ± 1877 13028 ± 2017 11010 ± 1742 8625 ± 784 21071 ± 1272
8 sifB-lacZ 2209 ± 503 1085 ± 77 711 ± 89 49 ± 3 1264 ± 139 1074 ± 207 43 ± 6 14677 ± 1092 43 ± 8
9 sseI-lacZ 3543 ± 314 119 ± 23 168 ± 40 130 ± 19 127 ± 32 128 ± 25 108 ± 16 11049 ± 2830 165 ± 10
10 sseG-lacZ 3017 ± 780 1444 ± 93 700 ± 49 1503 ± 109 1146 ± 118 690 ± 121 1083 ± 96 4229 ± 221 802 ± 99
The lac fusion being measured is listed in the left column. The strain background is listed along the top. Each strain harbors a lac fusion to an effector and a plasmid encoding a regulator or the vector control. 
The values in bold are those showing greater than 3-fold differences compared to the MM + pWSK29 strain that are discussed in the text. Each value represents the mean of at least three experiments ± 
standard deviation. MM, multi-regulator mutant [∆ (avrA-invH)1 ssrB::cat sirA4::hyg].BMC Microbiology 2007, 7:3 http://www.biomedcentral.com/1471-2180/7/3
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introduced into an otherwise wild-type background carry-
ing a chromosomal slrP-lacZY fusion. None of the muta-
tions affected the expression of the slrP fusion (Figure 3).
This is consistent with the lack of a decrease in the multi-
mutant background and a previous report in which plas-
mid-encoded rtsA, hilC, and hilD had effects on slrP, but
little or no difference in expression was seen with the
same regulators expressed from the chromosome [25].
• TTSS2 effectors
Regardless of growth condition, four of the five fusions to
TTSS2 effector genes (sspH2, sifB, sseI, and sseG) were acti-
vated by the ssrB-encoding plasmid (Tables 1 and 2). This
confirms the known activation of these genes by the ssrAB
two-component system [29,44,45]. Expression of the sifA
fusion was not affected in the multi-mutant background
compared to the wild-type, regardless of growth condi-
tion. Additionally, none of the plasmid-encoded regula-
tors altered sifA expression. This result was unexpected
since the expression of sifA has previously been shown to
depend on ssrA, which encodes the sensor kinase compo-
nent of the SsrAB two-component system [44].
To try to reconcile this discrepancy, we constructed a sec-
ond chromosomal lac fusion to sifA using the method
developed by Ellermeier et al. (see Methods). This fusion
was moved into the wild type and the multi-mutant back-
grounds. The multi-mutant strain was then transformed
with the ssrB-encoding plasmid or the pWSK29 vector.
This sifA  fusion was not regulated by ssrB  under SPI1-
inducing conditions and was only regulated 2-fold under
SPI2-inducing conditions (Table 3). SifA expression was
almost twice as high in the wild-type strain as it was in
either the ∆ssrA, ∆ssrB, or ∆ssrAB strains. Furthermore, sifA
expression was 2-fold higher in the multi-mutant back-
ground containing the ssrB plasmid than it was in the vec-
tor control strain (Table 3).
To test the regulation of sifA by ssrB in another way, we
constructed a plasmid that harbours the luxCDABE
operon from Photorhabdus luminescens under the control
of the sifA promoter. This plasmid was placed into the
wild type, the ssrA mutant, and the ssrB mutant containing
either the pssrB  plasmid or the vector control. These
strains were grown in LB or MgM media and the light
emitted by the cells captured using a Xenogen IVIS imag-
ing system (Alameda, CA) (Figure 4A) and measured
using a luminometer (Figure 4B). The light emitted by the
wild type strain is higher in MgM compared to LB showing
that the PsifA promoter is induced in the MgM medium
(Figure 4). The activity of the PsifA also decreased strongly
in the ssrA and the ssrB mutants after growth in both MgM
and LB. The pssrB plasmid restored the production of light
in the ssrB mutant (Figure 4). These results are consistent
with previous findings that sifA is regulated by the ssrAB
two-component regulatory system. It is not clear why the
regulatory effects are seen so clearly with plasmid-
encoded fusions and not observed with chromosomal
fusions. It is possible that additional layers of regulation
are imposed on the chromosomal fusions such as super-
coiling or chromatin structure that are relieved on the
plasmid.
Expression of the sifB  fusion was activated by ssrB, as
expected [29,44,45]. However, sifB was also repressed by
sirA, hilC, and invF. This is an interesting and novel result
because a TTSS2 effector is being repressed by the SPI1
regulatory cascade. No other effectors are activated by one
system and repressed by the other. Even more unusual is
that sirA and hilC had their effects in the multi-mutant
Table 3: Regulation of sifA by ssrAB.
LB MgM
WT sifA-lac 5.5 ± 1.6 26.3 ± 4.8
MM sifA-lac 3.6 ± 0.5 16.8 ± 2.9
MM sifA-lac + p-ssrB 4.8 ± 0.8 29.6 ± 6.9
MM sifA-lac + pWSK29 3.8 ± 0.5 15 ± 5.6
∆ ssrA sifA-lac 3.8 ± 1.1 14.4 ± 2.7
∆ ssrB sifA-lac 3.9 ± 1.4 14.2 ± 2.5
∆ ssrAB sifA-lac 2.7 ± 2.4 15.6 ± 2.6
The β-galactosidase activities of strains harbouring a sifA-lac fusion 
were measured using ONPG. Each value represents the mean Miller 
units of at least three experiments ± standard deviation. WT, wild 
type 14028; MM, multi-mutant [∆(avrA-invH)1 ssrB::cat sirA4::hyg].
Effect of chromosomal regulators on the expression of slrP Figure 3
Effect of chromosomal regulators on the expression of slrP. 
β-galactosidase assays were performed on log-phase cultures 
(using Beta-glo reagent). The results represent a mean of at 
least three independent assays. WT, wild type; invF, invF 
mutant; sicA, sicA mutant; sprB, sprB mutant, MM + pinvF-
sicA, multi-mutant containing the plasmid encoding invF and 
sicA; MM + psprB, multi-mutant containing the plasmid 
encoding sprB.
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background lacking invF. This indicates that sirA and hilC
are acting on sifB independently of the standard SPI1 reg-
ulatory pathway.
Conclusion
We have taken a systematic approach to study the regula-
tion of type III effector genes during growth in vitro. Our
results confirm that sopA and sopB are activated by invF-
sicA. In addition we have determined that sopE2 and sspH1
are regulated by invF-sicA. The regulation of sopE2 is very
strong under either SPI1 or SPI2-inducing conditions
while the regulation of sspH1 is weak and only observed
under SPI1-inducing conditions. The sspH2, sifB, sseI and
sseG fusions were shown to be strongly activated by ssrB.
The most interesting regulation was observed with sifA
and sifB. Chromosomal fusions to sifA were largely unaf-
fected by any regulator. However, a plasmid-based sifA
fusion was strongly regulated by ssrB. The sifB fusion was
strongly regulated by ssrB, as expected. However, it was
also strongly repressed by sirA, hilC, and invF. This is the
ssrB activates the promoter of sifA Figure 4
ssrB activates the promoter of sifA. The expression of the luxCDABE operon under the control of the PsifA promoter was ana-
lyzed in the wild type and the isogenic ssrA mutant and ssrB mutant with or without complementation. A, the strains were 
grown in MgM or in LB for six hours, and the light emitted by bacterial suspensions of similar cell density were captured using 
the Xenogen IVIS imaging system (Alameda, CA) and displayed as pseudocolor images with blue representing the lowest and 
red the highest light intensity. 1, wild type + PsifA-lux; 2, wild type + pSB384 vector control; 3, ssrA + PsifA-lux; 4, ssrB + PsifA-lux; 
5, ssrB + PsifA-lux + pssrB; 6, ssrB + PsifA-lux + pWSK29 control. B, quantification of the activation of the PsifA promoter. The 
light emitted by 100 microliters of culture was measured using a luminometer. The values represent the mean ± SEM of three 
independent experiments.
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first indication that sirA and hilC might regulate an effec-
tor gene independently of invF. The set of strains con-
structed for this study can now be used to quickly and
systematically study the regulation of newly identified
effector genes.
Methods
Growth conditions, enzymes, reagents, and transduction
The strains and plasmids used in this study are described
in Additional file 1. The bacterial strains were grown in LB
(Luria-Bertani) medium at 37°C. For induction in the
Magnesium minimal medium (MgM) [46] cells from LB
overnight cultures were washed with MgM prior to 1:50
dilution. The following antibiotics were obtained from
Sigma and used at the following concentrations when
required: kanamycin (kan, 50 µg/ml), ampicillin (amp,
100 µg/ml), chloramphenicol (cam, 20 µg/ml), tetracy-
cline (tet, 20 µg/ml), and hygromycin (hyg, 200 µg/ml).
Sucrose was supplemented at 219 mM final concentration
to select against sacB. The β-galactosidase chromogenic
substrate 5-bromo-4-chloro-3-indolyl-β-D-galactopyran-
oside (X-Gal) was obtained from Molecular Probes
(Eugene, OR) and used at a final concentration of 40 µg/
ml.
General molecular biology techniques were performed
essentially as described [47]. Restriction and modification
enzymes were purchased from Invitrogen (Carlsbad, CA)
or New England Biolabs (Beverly, MA), and used as rec-
ommended by the manufacturers. PCR primers were pur-
chased from IDT Inc. (Coralville, IA). Plasmids were
extracted using kits from Qiagen (Valencia, CA). P22
transduction was performed as described [48].
β-galactosidase assay
The  β-galactosidase activities were measured using o-
nitrophenyl  β-D-galactopyranoside (ONPG, Sigma, St.
Louis MO) using the method described by Miller [49] or
the Beta-Glo™ assay system (Promega, WI) according to
the manufacturer's recommendations. Briefly the assay
consisted of mixing an equal volume of a log phase grow-
ing culture (OD590 0.2–0.8) and a detection reagent. The
latter contains (i) a luciferin-galactoside substrate (6-O-β-
galactopyranosyl-luciferin) that is cleaved by the β-galac-
tosidase to form luciferin and galactose, and (ii) a firefly
luciferase that catalyzes the luciferin to generate light.
After at least 1 hour of incubation at room temperature
the light produced is measured in a Turner Designs TD-
20/20 luminometer or a Wallac 1420 VICTOR3  plate
reader and the results expressed as light per OD595 per µl
of culture. The results were expressed as the mean ± SD of
at least three different experiments.
Mutation of regulatory genes
The invF, sicA, sprB, ssrA, and ssrB genes were replaced with
the cat cassette from pKD3 using the λ-red recombination
system as described [50].
Construction of a multi-regulator mutant strain
The TTSS genes of SPI1 (~35 kb), but not the manganese
transport genes [51], were deleted using the pRE112 sui-
cide vector [52]. This deleted avrA through invH. To do
this, PCR was performed using primers BA1093 and
BA1094 (see Additional file 2) with 14028 genomic DNA
as template. The 1366 bp product contains the 3' end of
the invH gene, stm2901, and the 5' end of stm2902. A sec-
ond PCR was performed using primers BA1095 and
BA1096 (see Additional file 2). The 1255 bp product con-
tains the 3' end of sitC, the sitD gene, and the 5' part of the
avrA gene. Both products were cloned into pCR2.1 Topo
(Invitrogen). The sitD-containing fragment was removed
with SacI and cloned into the SacI site of the stm2901-con-
taining clone. This placed the two fragments adjacent to
each other and created the ∆(avrA-invH)1 deletion. This
2894 bp fragment was removed with KpnI and PvuII and
cloned into the suicide vector pRE112 that had been
digested with KpnI and SmaI to yield the plasmid pYD25.
This plasmid contains (i) a cat gene that confers a resist-
ance to chloramphenicol, (ii) the R6K replication origin
that requires the pir gene, and (iii) the sacB gene of Bacillus
subtilis that is toxic in Gram-negative bacteria grown in the
presence of high concentrations of sucrose [53]. Allelic
exchange was performed by mobilizing pYD25 from
BW20767 into JVR140 (sirA4::hyg). The chloramphenicol
resistant transconjugants harbor the pYD25 plasmid inte-
grated into the chromosome, resulting in the duplication
of the region upstream and downstream of TTSS1. Iso-
lated colonies were grown in LB without chloramphenicol
selection until the exponential phase and plated onto LB
lacking NaCl and containing 219 mM sucrose to select for
loss of the integrated plasmid by homologous recombina-
tion. The colonies obtained were screened for ∆(avrA-
invH)1 using PCR with primers hybridizing upstream and
downstream of the TTSS1 region. Finally, the resulting
∆(avrA-invH)1 sirA4::hyg strain was used as a recipient for
the P22HTint transduction of an ssrB::cat mutation from
MJW129 [29] to make the multi-mutant YD038 strain.
YD038 lacks the co-regulator sicA, and seven regulators,
sirA, ssrB, hilA, hilC, hilD, invF, and sprB.
Construction of lacZY fusions to effector genes
To make lacZY transcriptional fusions to effector genes,
the 3' portion of each gene (including the stop codon but
without the transcription terminator) was amplified using
PCR and cloned into pCR2.1 TOPO (Invitrogen,
Carlsbad, CA). These gene portions were then removed as
EcoRI fragments and cloned into the EcoRI site upstream
of the promoterless lacZY  gene of the pVIK112 pir-BMC Microbiology 2007, 7:3 http://www.biomedcentral.com/1471-2180/7/3
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dependent suicide vector [54]. The resulting plasmids
were mobilized from BW20767 into YD038. The correct
integration of the plasmids into the chromosome of the
resulting kanamycin-resistant transconjugants was veri-
fied by PCR. Fusions were transduced using phage
P22HTint into other backgrounds as needed. A second
fusion to sifA  was constructed as described previously
[55]. First the lambda red recombination system was used
to integrate a kanamycin resistance gene flanked by FRT
(Flp recombinase target) sites from the pKD4 plasmid
[50]. The FRT-kan-FRT cassette was placed after the stop
codon, but before the transcription terminator, of sifA.
Second, the temperature sensitive pCP20 plasmid [56]
that encodes Flp recombinase was introduced into the
strain. Flp-mediated excision of the kan cassette left a sin-
gle FRT site that serves as an integration point for the
fusion. The third step was to integrate the pCE36 suicide
plasmid that has a FRT site directly upstream of the pro-
moterless lacZY [55]. After the integration of pCE36, the
pCP20 plasmid was cured by growth at 37°C.
Construction of plasmids encoding regulators of the 
Salmonella type III secretion systems
Each of the regulatory genes missing in the multi-mutant
was amplified using PCR (the primers used are described
in Additional file 2), cloned into the pCR2.1 TOPO vec-
tor, released by enzymatic digestion and cloned under the
control of the lac promoter of pWSK29. The hilD, sirA, and
hilA genes were released from the TOPO vector as 1353 bp
SacI-XbaI, 936 bp KpnI-XhoI, and 1920 bp EcoRI fragments
respectively and cloned into the corresponding sites of
pWSK29 to yield the plasmids pYD17, pYD28 and pYD29
respectively. The 971 bp SpeI-XhoI fragment containing
the  sprB  gene was cloned into the XbaI-XhoI sites of
pWSK29 to give the pYD15 plasmid. The hilC gene was
released as a 1541 bp PvuII-XbaI fragment and ligated to
the EcoRV-XbaI sites of pWSK29 to produce the plasmid
pYD16. A 852 bp EcoRI fragment and a 622 bp KpnI-XhoI
fragment containing the invF  and the sicA  genes were
cloned into the corresponding sites of pWSK29 to yield
the plasmids pYD23 and pYD38 respectively. The 5353
bp ApaLI-XhoI fragment from pYD23 was ligated to the
1527 ApaLI-XhoI fragment from pYD38 to give the pYD40
plasmid that harbours the invF and sicA genes as a bi-cis-
tronic operon under the control of the lac promoter. Each
construction was verified by the complementation of a
corresponding regulatory mutant (Figure 2), except for
sprB for which a complementable function has not yet
been discovered [18]. We sequenced both strands of the
Plac-sprB region of the sprB-encoding plasmid to ensure
that the sequence was correct.
Construction of the PsifA-lux reporter plasmid
The promoter region and the 5'part of the sifA gene was
PCR-amplified from 14028 genomic DNA using the prim-
ers YD1 and YD2 (see Additional file 2). The product was
cloned into the pCR2.1 TOPO vector (Invitrogen) and
then released as an EcoRI fragment that was subsequently
cloned upstream of the luxCDABE operon of the pSB384
vector [57]. The correct orientation of the PsifA promoter
in the resulting pYD56 plasmid was verified by PCR.
Cell imaging and luminometry
Liquid cultures were grown in LB or MgM media for six
hours. The cultures were brought to similar OD600 and
200  µl of cell suspensions were placed in tubes and
imaged using the Xenogen IVIS imaging system (Alameda,
CA). The images are displayed as pseudocolors with blue
representing the lowest and red the highest light intensity.
For luminometry the light emitted by 100 µl of culture
was measured using a Turner Designs TD-20/20 lumi-
nometer.
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